1h Free Analyst Time
Chembio Diagnostic Inc (CEMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases including COVID-19, sexually transmitted disease, and fever and tropical disease. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers products to medical laboratories and hospitals, governmental, non-governmental organizations, and public health entities, medical professionals and retailers. The company distributes products through a network of distributors worldwide. Chembio is headquartered in Hauppauge, New York, the US.Chembio Diagnostic Inc Key Recent Developments
Aug 04, 2022: Chembio Diagnostics Reports Second Quarter 2022 Financial ResultsMay 24, 2022: Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors
May 17, 2022: Chembio Diagnostics announces agreement for Reszon Diagnostics International to manufacture Chembio’s HIV 1/2 STAT-PAK assay at Chembio Diagnostics Malaysia facility
Mar 03, 2022: Chembio Diagnostics Reports Fourth Quarter and Full Year 2021 Financial Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company- Chembio Diagnostic Inc - Key Facts
- Chembio Diagnostic Inc - Key Employees
- Chembio Diagnostic Inc - Key Employee Biographies
- Chembio Diagnostic Inc - Major Products and Services
- Chembio Diagnostic Inc - History
- Chembio Diagnostic Inc - Company Statement
- Chembio Diagnostic Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Chembio Diagnostic Inc - Business Description
- Product Category: Government Grant Income
- Performance
- Product Category: License and Royalty Revenue
- Performance
- Product Category: Product Sales
- Performance
- Product Category: R&D Revenue
- Performance
- Geographical Segment: Africa
- Performance
- Geographical Segment: Asia
- Performance
- Geographical Segment: Europe and Middle East
- Performance
- Geographical Segment: Latin America
- Performance
- Geographical Segment: The US
- Performance
- R&D Overview
- Chembio Diagnostic Inc - Corporate Strategy
- Chembio Diagnostic Inc - SWOT Analysis
- SWOT Analysis - Overview
- Chembio Diagnostic Inc - Strengths
- Chembio Diagnostic Inc - Weaknesses
- Chembio Diagnostic Inc - Opportunities
- Chembio Diagnostic Inc - Threats
- Chembio Diagnostic Inc - Key Competitors
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2016 to YTD 2022
- Chembio Diagnostic Inc, Medical Equipment, Deals By Type, 2016 to YTD 2022
- Chembio Diagnostic Inc, Recent Deals Summary
- Aug 04, 2022: Chembio Diagnostics Reports Second Quarter 2022 Financial Results
- May 24, 2022: Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors
- May 17, 2022: Chembio Diagnostics announces agreement for Reszon Diagnostics International to manufacture Chembio’s HIV 1/2 STAT-PAK assay at Chembio Diagnostics Malaysia facility
- Mar 03, 2022: Chembio Diagnostics Reports Fourth Quarter and Full Year 2021 Financial Results
- Jan 05, 2022: Chembio Diagnostics Announces Appointment of Larry Steenvoorden as Chief Financial Officer
- Mar 11, 2021: Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results
- Mar 08, 2021: Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors
- Feb 25, 2021: Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021
- Methodology
- Ratio Definitions
- About the Publisher
- Contact the Publisher
- Disclaimer
- Chembio Diagnostic Inc, Key Facts
- Chembio Diagnostic Inc, Key Employees
- Chembio Diagnostic Inc, Key Employee Biographies
- Chembio Diagnostic Inc, Major Products and Services
- Chembio Diagnostic Inc, History
- Chembio Diagnostic Inc, Subsidiaries
- Chembio Diagnostic Inc, Key Competitors
- Chembio Diagnostic Inc, Ratios based on current share price
- Chembio Diagnostic Inc, Annual Ratios
- Chembio Diagnostic Inc, Interim Ratios
- Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2016 to YTD 2022
- Chembio Diagnostic Inc, Medical Equipment, Deals By Type, 2016 to YTD 2022
- Chembio Diagnostic Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- Chembio Diagnostic Inc, Performance Chart (2017 - 2021)
- Chembio Diagnostic Inc, Ratio Charts
- Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2016 to YTD 2022
- Chembio Diagnostic Inc, Medical Equipment, Deals by Type, 2016 to YTD 2022
Companies Mentioned
A selection of companies mentioned in this report includes:
- Universal Biosensors Inc
- Roche Molecular Systems Inc
- OraSure Technologies Inc
- Maxim Biomedical Inc
- Corgenix Medical Corp
- bioLytical Laboratories Inc
- Abbott Laboratories